A purple and pink letter v on a white background.
November 14, 2019

Offer a Complete Acne Solution with Venus Versa™

In the United States, Canada, and more westernized societies, studies suggest  that acne breakouts are essentially a universal experience with 75–95% of adolescents experiencing some degree of acne vulgaris. In the U.S. alone, some 50 million people have acne at any one time. Part of the experience for most who suffer from acne is the struggle to control breakouts followed by the fear of scarring. Finding the right acne solution that results in clear, healthy skin can be a frustrating and draining process. It involves testing out different topical, prescription, or dietary solutions to see what just might work for them.

There is an opportunity in this area for aesthetics treatment providers to offer a comprehensive solution for acne patients. With just two applicators and the Venus Versa™ multi-treatment platform, paired with effective ongoing skin care, you can provide these prospective patients with a holistic acne treatment plan that reduces acne-related redness and inflammation, kills acne bacteria to prevent future breakouts, and minimizes the appearance of existing acne scarring for a brighter, clearer, healthier-looking complexion.

Step 1: Reduce Acne with Venus Versa

Using the AC Dual applicator equipped with Intense Pulsed Light (IPL) technology, Venus Versa™ acne reduction treatments  utilize a dual-wavelength approach to target acne-causing bacteria while promoting the healing of breakouts. Blue light targets porphyrins—organic compounds that are produced by P. Acnes bacteria—destroying the bacteria to prevent future breakouts. Red light, delivered in a longer wavelength, penetrates deeper into the skin and targets dilated blood vessels and oxyhemoglobin, reducing inflammation and likely allowing faster recovery of the sebaceous glands . Furthermore, the applicator features a built-in real-time cooling system that monitors temperature 1,000 times/second to better ensure patient safety and comfort. Typically, traditional acne treatments focus on just one of two aspects—treating the cause or reducing the visible symptoms. Venus Versa™’s dual approach cuts down on treatment steps for patients and delivers effective results with just one treatment plan. Additionally, treatment sessions typically last from 15 to 20 minutes, making this option even more attractive to your prospective patients with busy schedules who are seeking a simple solution that works.

Step 2: Reduce Acne Scarring with Venus Versa  

When equipped with the NanoFractional Radio Frequency (RF) with SmartScan applicator, Venus Versa™ offers a non-invasive fractional ablation system that harnesses the power of radio frequency (RF) technology  to resurface the skin, improving the appearance of acne scars and other signs of uneven skin texture for smoother, more even-toned skin. The applicator tip features a spot size that is one of the largest in the industry and treatments require no anesthesia, making quicker work of treatment sessions to allow for a smoother schedule— a key factor for improved patient retention. SmartScan technology uniquely distributes energy across a small footprint per pin and at variable energy densities to ensure sufficient tissue is left intact between each microdermal wound. This promotes faster healing, minimal downtime, lower occurrence of PIH, and greater patient comfort. When used to follow up an acne reduction treatment plan, the result is a comprehensive, fully customizable plan that ensures your patients can keep up with their busy lives without having to put their aesthetic goals on the backburner.

Step 3: Provide Long-Term Support for Skin Health

It is advised that patients are made aware that some maintenance treatments may be required to ensure long-term skin health. However, you might also consider additional options that can better support the patient’s   skin care while establishing a more loyal aesthetics client base. For patients whose acne may be a result of excess sebum production, regular Venus Glow™ dermal rejuvenation treatments  may help. Venus Glow™ treatments utilize a powerful tri-modality approach to deep-clean pores. This helps to reduce bacteria buildup and control sebum secretion, so patients may better maintain their noticeably healthier, natural glow with less worry regarding the return of acne breakouts. Venus Glow™ treatments also help to restore skin hydration while increasing local micro-blood circulation to help boost skin’s natural collagen and elastin production levels, which can help to complement results from some of your clinic’s other aesthetics treatments.  

Interested in learning more about how you can expand your acne treatment services with Venus Versa™  and Venus Glow™? Contact an expert today using the link below to get started.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.